Harrow Health Inc (HROW)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

12264 EL CAMINO REAL SAN DIEGO, CA 92130

Transdel Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of non-invasive topically delivered medications. The company's lead topical drug candidate, Ketotransdel, utilizes its proprietary Transdel cream formulation to facilitate the passage of ketoprofen, a non-steroidal anti-inflammatory drug (NSAID), through the epidermis and into underlying tissues. Ketotransdel provides an alternative to the oral administration of cyclooxygenase-2 selective NSAIDs (COX-2 inhibitors) and non-selective NSAIDs. It has completed a Phase 1/2 trial for treating soft tissue pain and soreness in a delayed onset muscle soreness model with Ketotransdel. Transdel Pharmaceuticals also investigates other drug candidates and treatments for transdermal delivery using Transdel technology, including anesthetics, human hormone replacement, and anti-nausea medications. The company was founded in 1998 and is headquartered in La Jolla, California.

Data based on most recent fiscal year report
Market Cap147.35 Million Shares Outstanding21.05 Million Avg Volume315.077 Thousand
1-Yr BETA vs S&P TR1.073 Current Ratio1.53 Quick Ratio1.14
View SEC Filings from HROW instead.

View recent insider trading info

Funds Holding HROW (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding HROW BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

72.2 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

OPALEYE MANAGEMENT INC.

  • PREVIOUSLY A 10% OWNER
5,122,500 2020-04-03 0

AUSTIN STEPHEN G

  • Director
91,987 2020-03-16 2

SPARKS TERESA

  • Director
0 2020-03-16 2

BAUM MARK L

  • Director
0 2020-03-12 3

LINDSTROM RICHARD L MD

  • Director
0 2020-03-10 1

SWANN LYNN C

26,088 2020-02-18 0

LONGBOARD CAPITAL ADVISORS, LLC

CONRAD BRETT

  • 10% Owner
  • MANAGING MEMBER
3,777,318 2020-01-28 0

BOLL ANDREW R. CHIEF FINANCIAL OFFICER

  • Officer
0 2020-01-02 3

KAMMER ROBERT J

  • Director
797,327 2019-11-11 8

BONFIGLIO JOHN N CHIEF OPERATING OFFICER

  • Officer
37,500 2019-07-01 0

PRINCIPI ANTHONY

  • Director
0 2019-06-26 1

THORNLEY ANTHONY S

  • Director
49,536 2019-05-07 0

SAHAREK JOHN P. CHIEF COMMERCIAL OFFICER

  • Officer
0 2019-02-19 0

KENNY PETER C

  • Director
8,600 2017-05-17 0

EDWARDS CLAYTON D CHIEF OPERATING OFFICER

  • Officer
0 2017-04-13 0

NELSON WILLIAM H.

  • Director
0 2016-06-10 0

MILONI DONALD PAUL

  • 10% Owner
No longer subject to file 2015-05-18 0

BASSANI AUGUST SHELBY

  • Director
13,488 2014-09-04 0

FINNEGAN PAUL

  • Director
6,865 2013-06-27 0

ABRAMS JEFFREY J

  • Director
45,927 2013-06-27 0

SCHUPP JOACHIM PH CHIEF MEDICAL OFFICER

  • Officer
0 2013-04-01 0

PROFESSIONAL COMPOUNDING CENTERS OF AMERICA, INC.

  • 10% Owner
832,682 2012-08-31 0

DERMASTAR INTERNATIONAL, LLC

  • 10% Owner
0 2012-06-29 0

LADONNIKOV ALEXEJ

  • 10% Owner
1,984,156 2012-02-28 0

BRAR BALBIR

  • Director
66,022 2012-01-23 0

NIDA TERRY CHIEF BUSINESS OFFICER

  • Officer
0 2010-02-26 0

SINGH JULIET CEO, DIRECTOR AND PRESIDENT

  • Officer
  • Director
  • 10% Owner
0 2009-06-18 0

LOMORO JOHN T CHIEF FINANCIAL OFFICER

  • Officer
0 2009-06-18 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

AUSTIN STEPHEN G - Director

2020-03-16 M 72,218 a 91,987 91,987.00 direct

SPARKS TERESA - Director

2020-03-16 A 10,000 a 10,000 0.00 direct

AUSTIN STEPHEN G - Director

2020-03-16 M 34,091 d 9,715 91,987.00 direct

AUSTIN STEPHEN G - Director

2020-03-16 M 12,690 d 59,529 91,987.00 direct

AUSTIN STEPHEN G - Director

2020-03-16 M 9,715 d 0 91,987.00 direct

AUSTIN STEPHEN G - Director

2020-03-16 M 15,723 d 43,806 91,987.00 direct

Elevate your investments